Merck & Co Inc (MRK)
130.40
+0.85
(+0.66%)
USD |
NYSE |
May 09, 15:14
Merck Cash from Financing (TTM): -5.57B for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -5.57B |
December 31, 2023 | -4.81B |
September 30, 2023 | -4.119B |
June 30, 2023 | -2.552B |
March 31, 2023 | -8.087B |
December 31, 2022 | -9.119B |
September 30, 2022 | -2.358B |
June 30, 2022 | -1.93B |
March 31, 2022 | 1.605B |
December 31, 2021 | 2.593B |
September 30, 2021 | -1.242B |
June 30, 2021 | -2.819B |
March 31, 2021 | -3.44B |
December 31, 2020 | -2.832B |
September 30, 2020 | -6.215B |
June 30, 2020 | -5.516B |
March 31, 2020 | -8.737B |
December 31, 2019 | -8.861B |
September 30, 2019 | -12.42B |
June 30, 2019 | -11.17B |
March 31, 2019 | -12.05B |
December 31, 2018 | -13.16B |
September 30, 2018 | -13.38B |
June 30, 2018 | -10.94B |
March 31, 2018 | -14.19B |
Date | Value |
---|---|
December 31, 2017 | -10.01B |
September 30, 2017 | -6.198B |
June 30, 2017 | -7.569B |
March 31, 2017 | -4.717B |
December 31, 2016 | -9.044B |
September 30, 2016 | -9.473B |
June 30, 2016 | -11.18B |
March 31, 2016 | -13.41B |
December 31, 2015 | -5.387B |
September 30, 2015 | -12.75B |
June 30, 2015 | -8.935B |
March 31, 2015 | -11.71B |
December 31, 2014 | -15.24B |
September 30, 2014 | -8.094B |
June 30, 2014 | -12.29B |
March 31, 2014 | -2.949B |
December 31, 2013 | -5.99B |
September 30, 2013 | -4.584B |
June 30, 2013 | -2.407B |
March 31, 2013 | -3.963B |
December 31, 2012 | -3.267B |
September 30, 2012 | -4.28B |
June 30, 2012 | -5.786B |
March 31, 2012 | -6.457B |
December 31, 2011 | -6.904B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-12.42B
Minimum
Sep 2019
2.593B
Maximum
Dec 2021
-4.880B
Average
-4.464B
Median
Cash from Financing (TTM) Benchmarks
Amgen Inc | -2.169B |
Johnson & Johnson | -21.42B |
Eli Lilly and Co | 2.772B |
Pfizer Inc | 23.91B |
Moderna Inc | -821.00M |